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ABSTRACT
Background: The p53-up-regulated modulator of apoptosis (PUMA) protein is a proapoptotic, BH3-only member of the BCL2 family of effector proteins responsible for promoting
organized cell death. PUMA is required for resolution of pneumococcal pneumonia in mice, as
mice deficient of PUMA exhibit greater numbers of S. pneumoniae CFU within tissues and
higher mortality rates than observed in Puma+/+ mice.
Methods: Puma+/+ and Puma-/- mice were intranasally challenged with TIGR4
pneumococcus and sacrificed 24 h post-infection. Differences in cytokine levels from blood and
whole lung tissue were detected by MILLIPLEX MAP Mouse Cytokine/Chemokine Magnetic
Bead Panel. Lung transcriptomes from Puma+/+ and Puma-/- mice were prepared from total lung
RNA using NEBNext Poly(A) mRNA Magnetic Isolation Module and NEBNext Ultra RNA
Library Prep Kit for Illumina. Libraries were read by Illumina NovaSeq and transcript reads
were referenced to Mus musculus.
Results: Puma-/- mice exhibited significant differences in G-CSF, GM-CSF, IFN-gamma,
IL-1-alpha and -beta, -6, -9, -10, -12 (p40 and p70), -13, and -17, IP-10, KC, MCP-1, MIPiii

1alpha and -beta, MIP-2, RANTES, and TNF-alpha compared to Puma+/+ mice. Puma-/- lungs
exhibited higher levels of IL-12, IFN-gamma, and IP-10. Loss of PUMA also resulted in
expression of the pro-angiogenic genes Adam19 and Neurexin2. Additionally, Puma+/+ and
Puma-/- mice displayed similar levels of colonization, but Puma-/- mice were more susceptible to
subsequent dissemination to the lungs and blood.
Conclusion: Polymorphonuclear cells (PMNs) were previously demonstrated to be one
of the innate cell types responsible for Puma-dependent resolution of pneumococcal pneumonia
in mice. Observations reported here suggest that this resolution is propelled by suppressing the
inflammatory response via the inhibition of IL-12/IFN-gamma/IP-10 pro-inflammatory axis.
Pulmonary tissue transcriptomic analysis also suggests PUMA-dependent positive regulation of
homeostatic control of pulmonary vasculature, smooth muscle innervation, and maintenance of
the interstitium. Gene ontological analysis further demonstrated Puma’s modulatory role in
Type I and II IFN signaling. For the first time, we report Puma’s regulatory effects on proinflammatory cytokine signaling and gene expression during pneumococcal pneumonia.
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CHAPTER I
INTRODUCTION
Pneumococcal-disease epidemiology
Socioeconomic burden
Streptococcus pneumoniae (pneumococcus) is the causative agent of pneumococcal
disease (PD), which can be broadly categorized into two types: non-invasive (NIPD) and
invasive (IPD). PD primarily affects children and the elderly across populations, with agespecific pathological manifestations. NIPD primarily occurs in children and is presented as acute
otitis media, sinusitis, and resolving pneumonia, with resolving pneumonia occurring extensively
in the elderly (1). IPD, generally determined by isolation of pneumococcus from an otherwise
sterile tissue (e.g., blood; urine; cerebrospinal fluid; etc.), occurs when pneumococcal pneumonia
(PP) progresses to the point of dissemination, leading to septicemia and meningitis.
Pneumococcus is transmitted via respiratory droplets through airway mucosae from younger
individuals with PD or pneumococcal carriers (typically children) to uncolonized individuals (2–
4). PP, the main contributor to community-acquired pneumonia (CAP), causes the majority
healthcare- and economic-associated burden amongst adults with CAP (1). In the U.S.
population over 50 years of age, an estimated annual 500,000 cases of PP result in 30,000 IPD
cases and 25,000 consequent deaths. In adults, inpatient PP cases contribute to more than half of
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emergency room visits and nearly 90% of all CAP-related hospitalizations (5). While inpatient
and outpatient PP cases are estimated to account for little more than one-fifth of PD cases, PP
contributes approximately 75% of direct medical costs. In recent decades, multiple iterations of
pneumococcal conjugate vaccines (PCVs) have slowed the international, socioeconomic scourge
of IPD, but PCV efficacy ranges across age groups and not all nations have adopted vaccination
programs (6–8). Host populations continue to be at-risk due to two major factors: increased lack
of vaccine coverage and multi-drug resistance (MDR) among clinical isolates (9–14). In clinical
isolates from a range of pneumococcal infections among children in Shanghai, China, 88% were
MDR, with some not covered by the PCV (9). Similarly, some Japanese IPD and non-IPD
strains not covered by the PCV have also been found to be drug-resistant (10, 11). MDR strains
are also prevalent across Middle Eastern nations, where vaccination programs are not wellestablished (12). Non-PCV strains isolated in the United States across age groups also display
drug-resistance (13). In accordance with this observation, IPD and non-IPD infections constitute
a significant socioeconomic burden in the U.S. Drug-resistant strains attributed approximately
33,000 outpatient visits and 20,000 hospitalizations due to pneumococcal pneumonia with an
estimated $91 million in direct medical costs and $140 million in lost wages and productivity
(14). To compound these issues, vaccination-enhanced carriage of drug-resistant strains is
occurring across in Europe and Asia (15, 16). It is clear that the use, overuse, and abuse of
antibiotics and various iterations of vaccination campaigns against pneumococcus has
dramatically shifted the ecology of pneumococcal infection. Nearly 20% of the U.S. population
will be over age 65 by the year 2030 (17), and multiple serotypes are associated with elderly PP
(18). CAP due to pneumococcus leads to about 600,000 elderly hospitalizations per year with
higher lethality rates, contributing to the fifth leading cause of death among the elderly (4, 19).
2

Pneumococcal virulence factors
Pneumococcus is capable of producing many virulence factors that act directly or
indirectly in a number of capacities, including subverting the host immune response. The
primary virulence factor is the polysaccharide capsule, which repels bacteria from host mucus
and promotes adherence and nasopharyngeal colonization, undermines deposition of immune
complexes (complement and antibodies), subsequent phagocytosis by innate immune cells, and
allows evasion of neutrophilic extracellular traps (NETs) (19). Pneumolysin (PLY), a cytotoxin,
is secreted by a currently unknown mechanism and additionally released as a result of bacterial
autolysis, and in the presence of host cells, binds to intramembrane cholesterol and consequently
perforates cellular membranes causing lysis and cell death (19). Pneumococcus produces many
other proteinaceous virulence factors, including those that interfere with complement activity
(pneumococcal surface protein A (PspA) and choline-binding protein A (CbpA), aid in
colonization (autolysin, PspA, CbpA, LytB, LytC, CbpC, CbpG, pilli, and, neuraminidase), and
contribute to invasion of host cells (CbpA and PsaA) (19). However, these virulence factors are
not the focus of the present work and will not be discussed in detail further.
The focal point of pneumococcal virulence in the present study is hydrogen peroxide
(H2O2). Pyruvate oxidase and lactate oxidase, encoded by the spxB and lctO genes, respectively,
are responsible for the vast majority of H2O2 produced by pneumococcus and contributes to its
virulence with pyruvate oxidase being the primary producer of H2O2 (20). SpxB activity also
provides resistance to H2O2 toxicity in pneumococcus (21), acts in concert with lactate oxidase
during aerobic growth to maximize carbon utilization (22), and enhances capsule biosynthesis
via modulation of polysaccharide metabolism (23). Pneumococcal SpxB activity can lead to
autolysis if too much H2O2 is produced, although, due to the resistance of pneumococcus, can
3

afford a competitive advantage against other commensal flora in vivo during colonization (19,
24). Pyruvate oxidase activity also contributes to PLY release (25), which, along with H2O2 can
mediate programmed cell death (apoptosis) in brain cells during meningitis (26). Pneumococcal
H2O2 also promotes cell invasion and killing of cardiomyocytes (27). In lung cells, H2O2 causes
leakage of mitochondrial DNA and promotes Type I interferon (IFN) expression (28), induces
transcription of inflammatory cytokines (29), and leads to DNA damage-induced apoptosis in
lung cells (30). In PP models in mice, SpxB-produced H2O2 suppresses inflammasomedependent innate immune signaling (31). In human ciliated epithelium in vitro, H2O2 caused
ciliary slowing and epithelial damage (32).
Pneumococcal strain selection
Capsule serotype 4 pneumococcus is one of the predominant serotype groups isolated
from adults in Europe and the U.S. and is associated with enhanced invasiveness compared to
other serotypes during IPD (18). TIGR, a representative strain of serotype 4 (referred to from
hereon as TIGR4), is resistant to complement-mediated immunity (33, 34). TIGR4 enhances
formation of NETs in vivo during pathogenesis of PP, thereby augmenting tissue damage (35).
Dissemination during IPD by TIGR4 to the brain induces meningitis. However, TIGR4, once
phagocytosed by microglia, display resistance to intracellular killing, leading to replication of
bacteria (36). In addition to the increased severity of invasiveness of TIGR4 compared to most
other serotypes, TIGR4 significantly increases host production of pro-inflammatory cytokines
interleukin (IL)-1β and IL-6, both of which are considered primary instigators of the
inflammatory cascade during PP (37). For these reasons, TIGR4 was deemed a suitable
pathogen model to investigate the early phase of the innate immune response during PP.
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Innate immunity
Initiation of the innate response by pneumococcus
The innate cellular immune response to pneumococcus is initiated by respiratory airway
epithelium (19). The respiratory epithelium is composed of many types of cells, including those
that secrete mucus, those that are ciliated, and those that provide a physical barrier to foreign
particles (38, 39). Respiratory epithelial cells also secrete a multitude of cytokines, chemokines,
and antimicrobial compounds (39, 40). In murine models of PP, dissemination to pulmonary
tissues results in secretion of granulocyte-colony stimulating factor (G-CSF), granulocyte
macrophage-colony stimulating factor (GM-CSF), IL-1α, IL-1β, IL-6, IL-10, IL-12, IL-17,
interferon-inducible protein (IP)-10, macrophage chemotactic protein (MCP)-1, macrophage
inflammatory protein (MIP)-1α, MIP1-β, MIP-2, regulated upon activation, normal T-cell
expressed and secreted (RANTES) protein, tumor necrosis factor (TNF)-α, and interferon (IF)-ϒ
(41, 42, 51–58, 43–50). Together, these cytokines augment the cellular innate immune response
during PP.
Inflammation and neutrophil recruitment to the pneumonic lung
Though the mechanisms of neutrophil recruitment and activation have not yet been fully
elucidated, some details have been characterized (59–66). For instance, in addition to initiating
clearance of pathogens from the site of infection, macrophages secrete granulocyte colonystimulating factor (G-CSF), after exposure to IL-1 or TNF-α (41), as well as IL-8, TNF-α,
macrophage inflammatory protein 2 (MIP-2), and granulocytic chemotactic protein 2 (GCP-2)
(67, 68). IL-1, -6, -17, and CXC ligand 5 (CXCL5) have also been shown to recruit neutrophils
(69–71). The inflammatory cascade is highly regulated by many cell types and cytokines, some
of which antagonize others. IL-1, -6, -8, and -17, MIP-1, and TNF-α all primarily induce
5

inflammation, while IL-4, and -10 and transforming growth factor (TGF)-β predominantly serve
to limit inflammation (72). During PP, IL-6, -12, -17, and -18 and TNF-α have been observed as
integral in the innate immune response to pneumococcus.
Immunomodulation of the innate response by NF-κB
As the physiological processes of innate immune cells have been investigated over the
years, it has become increasingly evident that effector cells of the innate immune response are
not merely pre-programmed to carry out a limited set of cellular functions, but rather exhibit a
diverse array of inducible gene expression patterns. An integral regulator of these programs is
the transcriptional factor nuclear factor kappa B (NF-κB), which induces expression of genes
involved in the over-arching inflammatory process, including apoptosis and phagocytosis.
Interestingly, IL-8, MIP-2, and CXCL5 genes include binding sites corresponding to the
transcription factor NF-κB, with CXCL5 having been shown to be induced after IL-1 and TNF-α
exposure (68, 73). In line with these observations, NF-κB activation also induces upregulation
of IL-1β, -6, -8, TNF-α, GM-CSF, RANTES, MIP-1α, MCP-1 (74). Additionally,
pneumococcal-induced NF-κB activation in the lung was demonstrated to augment expression of
inflammatory cytokines and neutrophil recruitment (70, 75–78). Lipoproteins of S. pneumoniae
have been shown to elicit TLR- and NF-κB-mediated inflammatory responses during
pneumococcal infection (79). NF-κB activation by pneumococcus in human alveolar epithelial
cells also induces secretion of IL-6, -8, and TNF-α (80, 81). During inflammation, NF-κB
activation can also aid in resolution of inflammation and prevent a prolonged inflammatory
response correlated with tissue damage (82, 83).
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Pneumococcal H2O2, host ER stress, and inflammation
Stress in the endoplasmic reticulum (ER) can provide danger signals that initiate innate
inflammatory responses (84). Pneumococcal H2O2 induces dichotomous responses along the
mitochondrial-ER crosstalk axis in lung cells, inducing mitochondrial membrane leakage and
promoting Type I IFN expression (28). Pneumococcal H2O2 also activates NF-κB, induces ER
stress leading to the unfolded protein response, and promotes expression of inflammatory
cytokines (29, 85, 86). During PP, pneumococcal H2O2-induced ER stress is exacerbated by
ATF3-dependent stimulation of IL-17A expression through Ca2+/reactive oxygen species (ROS)dependent IL-1β activation (87). In aged lungs, pneumococcus augments ER stress and ER
stress-induced apoptosis in lung cells (88). However, ER stress-induced inflammation in aged
lung cells is undermined through suppression of the nucleotide-binding domain leucine-rich
repeat containing (NLR) family member NLRP3 during PP (89).
Modulation and resolution of inflammation
Once the inflammatory response has begun to elicit its effector functions, the response is
executed by a number of mechanisms, leading to either the resolution or propagation of
inflammation. The landscape of inflamed tissue is littered with excess fluid, opsonized
pathogens (e.g., immune complexes), and dead and dying neutrophils, expired due to a
combination of senescence and execution of their collective effector function. At this point, the
balance of the innate immune response is tipped either in favor of or against inflammation
resolution. To resolve inflammation, the accumulated debris must be cleared in an effective and
efficient manner, a process made possible by apoptosis, complement activation, cell signaling,
and phagocytic clearing. Some pathogens are capable of modulating granulocyte apoptosis (90–
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92). Apoptosis of neutrophils and macrophages heavily contribute to resolution of PP (93–95).
Not surprisingly, pneumococcus induces apoptosis and necrosis in neutrophils (96).
Neutrophil-pneumococcal interactions
Resolution of IPD is underpinned by neutrophil-dependent killing mechanisms (97). In
the host, these interactions are initiated by opsonophagocytosis, a process that is partially
disrupted by pneumococcal capsule (33, 34). However, neutrophils are the host’s primary
professional phagocytes and are highly effective in clearing foreign matter from host tissues.
Once phagocytosed by neutrophils, pneumococcus is quickly dispatched after fusion of the
phagolysosome with primary granules containing serine proteases cathepsin G and neutrophil
elastase, both of which are necessary for lung-protective immunity in the PP murine model (98–
100). The phagocytosis of pneumococcus culminates in apoptosis-dependent, phagocytosisinduced cell death (100–103).
PUMA and innate immunity
PUMA
Apoptosis is a tightly regulated process that occurs in a vast number of tissues and
contexts within the host. The primary regulatory effector proteins involved in modulation of
apoptosis is the BCL-2 protein family. Originally characterized in a B-cell lymphoma (Bcl)
model, approximately 300 proteins have further been characterized, with the common Bcl2
homology (BH) domains. BCL-2 members can be broadly categorized as pro-survival or proapoptotic based on functional activity (104, 105). Pro-survival members contain all four of the
BH domains and include the proteins BCL-2, BCL-XL, BCL-W, MCL-1, and A1. These BCL-2
members are primarily found integrated in the outer membranes of mitochondria, ER, and
8

nuclear membrane and bind to and directly inhibit pro-apoptotic members (106–108). Proapoptotic proteins are generally divided among those containing multiple BH domains, including
BAK and BAX, and those containing only BH3 domains. The BH3-only members can be
grouped further into activators, including PUMA, which directly activate BAK and BAX, and
enablers, such as PUMA, BID, and NOXA, which competitively bind pro-survival members
bound to BAK and BAX, thereby releasing the multi-domain proteins (109).
PUMA, first discovered in 2001 as a result of intensive cancer research, was initially
described as a p53-inducible gene, owing to its current moniker, the p53 up-regulated modulator
of apoptosis (PUMA) (110, 111). After its initial characterization, PUMA was studied primarily
within the context of cancer pathobiology (111–114). However, in 2010, PUMA was shown to
be necessary for neutrophil-mediated protection against lethal bacterial sepsis (97). Puma-/- mice
were significantly more susceptible to bacterial challenge with pneumococcus and died soon
after, with Puma-/- neutrophils less sensitive to apoptosis induced by H2O2.
p53-dependent apoptosis
The transcription factor p53 was first characterized as a tumor suppressor that inhibited
transcription of oncogenes (tumor causing genes). However, it has since been assigned multiple
roles, including transcriptional regulation, either directly or indirectly, of thousands of genes,
including some of those involved in apoptosis (115, 116). As an apoptotic effector, p53 can be
activated in response to pneumococcal-induced stress (97). Incidentally, p53 protein propagates
the eventual activation of caspases via its binding to anti-apoptotic proteins in the cytosol, thus
releasing other pro-apoptotic proteins, including PUMA (117–122). Protein p53 can also be
released from anti-apoptotic inhibitors through induction and subsequent binding of p53
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transcriptional targets, illustrating p53’s dual role as both transcriptional regulator and effector
molecule.
p53-independent PUMA expression
PUMA expression can also be triggered via p53-independent mechanisms. In murine
colon cancer models, PUMA expression is induced by NF-κB (120, 123–125). Multiple in vitro
models have also been used to demonstrate the role of NF-κB in PUMA regulation, including
cardiomyocytes, T-cells, and neutrophils (126–129). In a Gram-negative model of infection,
Helicobacter pylori induced PUMA expression in an NF-κB-dependent manner and PUMA
expression strongly correlated with gastric lesions (130). ER stress is also a source of p53independent PUMA expression, with the ER stress-associated transcription factor CHOP acting
as a direct trigger of PUMA expression (131–135). As a result of ER stress or DNA damage,
CHOP expression can be induced by metastatic cancers and pathogens of bacterial, fungal,
protozoan, and viral origin (136–143).
Dissertation summary
This dissertation primarily focuses on characterizing PUMA-dependent responses of the
host during the early stages of PP, specific inducers of Puma expression, and mechanisms of
Puma-dependent neutrophilic apoptosis (TABLE 1).
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Table 1.1

Proposal objectives and associated outcomes.

Objectives were oriented based upon the current gaps in knowledge of the field at the onset of
the project. Experimental design and investigative techniques were evaluated and implemented
based upon the current standards of the field at the time.
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CHAPTER II
PUMA LIMITS DEVELOPMENT OF THE CYTOKINE STORM AND ABBERANT
CHANGES IN THE PULMONARY TRANSCRIPTOME
Abstract
Apoptosis of cells at the site of infection is a requirement for shutdown of inflammatory
signaling, avoiding tissue damage, and preventing progression of sepsis. Puma+/+ and Puma-/mice were challenged with TIGR4 strain pneumococcus and cytokines were quantitated from
lungs and blood using a magnetic bead panel analysis. Puma-/- mice exhibited higher lung and
blood cytokine levels of several major inflammatory cytokines, including IL-6, G-CSF,
RANTES, IL-12, IFN-ϒ, and IP-10. Puma-/- mice were more susceptible to bacterial
dissemination and exhibited more weight loss than their wild-type counterparts. RNA
sequencing analysis of whole pulmonary tissue revealed Puma-dependent regulation of Nrxn2,
Adam19, and Eln. Enrichment of gene ontology groups for genes differentially expressed in
Puma-/- tissues strongly correlated to IFN-β and -ϒ signaling. Here, we demonstrate for the first
time the role of Puma in prohibition of the cytokine storm during bacterial pneumonia. These
findings further suggest a role for targeting immunomodulation of IFN signaling during
pulmonary inflammation. Additionally, our findings suggest previously undemonstrated roles
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for genes encoding regulatory and binding proteins during the early phase of the innate immune
response of pneumococcal pneumonia.
Introduction
During pneumococcal infection, interactions with host epithelium initiates recruitment of
neutrophils (144). Incidentally, activated neutrophils are capable of inducing apoptosis of
epithelial cells (145). Accordingly, pneumococcus can induce apoptosis in neutrophils (96, 146),
epithelial cells (147), and macrophages (148). In murine pneumococcal pneumonia, macrophage
apoptosis is crucial for limiting pulmonary inflammation (94). Pneumococcus can induce
apoptosis of numerous host respiratory cell types by multiple mechanisms, including PLY- and
cell wall component-dependent apoptosis of alveolar macrophages, epithelial cells, neutrophils,
and endothelial cells and H2O2-dependent DNA damage and apoptosis in lung cells (30, 149).
Apoptosis of cells at the infected site modulates innate immune signaling, cell fate of responding
phagocytes, promotes resolution of inflammation, and limits tissue damage (72, 90, 91, 93, 150,
151). The resultant effects of pneumococcal injury and apoptosis within the tissues strongly
correlates with wound healing and repair (152–156). Several experimental in vitro and in vivo
models and clinical studies have reported several pro-inflammatory cytokines up-regulated
during the early phase of pneumococcal pneumonia, including IL-6, G-CSF, TNF-α, IL-1β, IL12, IFN-ϒ, and IP-10 (40, 48, 161, 162, 49, 51, 55, 58, 157–160). However, the extent to which
these cytokines contribute to the much eluded to “cytokine storm” seen in severe pneumococcal
pneumonia and sepsis is currently unknown. Cytokines IL-6, TNF-α, IL-1β, IL-1RA, IFN-ϒ, IL12, and IP-10 have been implicated in pneumococcal pneumonia in clinical findings (72, 158,
159). In the last two decades, over-expression of IL-12, IFN-ϒ, and IP-10 has emerged as a
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highly potent pro-inflammatory neutrophil-mediated signaling axis in murine models of
pneumococcal pneumonia (48, 49, 51, 58, 163).
Neutrophils are the primary effector cells of the host innate response to pneumococcal
pneumonia (68). In pneumococcal pneumonia patients, the activation of neutrophils after
extravasation into the lungs delays the rate of spontaneous apoptosis (164). However, apoptosis
of neutrophils is an essential feature of pneumococcal infection, as apoptotic neutrophils must be
cleared from the site upon performing their effector functions (93, 165). Pneumococcus can
induce apoptosis in neutrophils in an H2O2-dependent fashion and accelerate apoptosis by PLY
membrane perforation at relatively lower multiplicities of infection (MOI) (96). MOI, the ratio
of infectious agent to infectious target, can be manipulated in experimental infection models to
study a varied array of pathogen-host cell interactions. Lower MOI are often employed to study
host cell apoptosis, while higher MOI are used to study necrotic cell death (166–168). PUMA is
one of the primary effector proteins that promotes apoptosis (110, 111, 116, 117, 169). PUMA is
a pro-apoptotic member of the BCL-2 superfamily of eukaryotic proteins involved in regulating
apoptosis. In a murine model of pneumococcal infection, neutrophil-mediated protection against
lethal dissemination of pneumococci was shown to be Puma-dependent (97). However, the
effects of Puma-dependent apoptosis on global gene expression and innate immune signaling in
the lung during the early phase of pneumococcal pneumonia has not been investigated. For the
first time, we have characterized the Puma-dependent inflammatory cytokine profile in mouse
during pneumococcal pneumonia.
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Materials & Methods
Bacterial culture
S. pneumoniae strain TIGR4 (170) was cultured overnight on TSA supplemented with
5% sheep’s blood (EMD Millipore) and subsequently inoculated into 10 mL pre-warmed C+Y
(171). TIGR4 was cultured to mid-log, centrifuged for 10 minutes at 15,871 x g and 4°C, and
resuspended in 1 mL of C+Y with 20% glycerol (Thermo Fisher Scientific). Resuspended
TIGR4 was aliquoted by volumes of 100 μL and stored at -80°C until used in animal challenges.
Before challenging animals, one aliquot TIGR4 was removed, serially diluted in 1X PBS
(Thermo Fisher Scientific), cultured on blood agar overnight, and quantitated. Additional strains
(EF3030 and TIGR4:ΔspxB) were likewise prepared and quantitated.

Animal handling and challenges
All experiments involving animals were planned and conducted in accordance with
guidelines of the MSU Institutional Animal Care and Use Committee (Protocol number 19-537).
The committee-approved procedures performed in the study presented here. C57BL/6 mice were
maintained at Biosafety Level 1 and 2 facilities in the Mississippi State University Animal
Facility within Harned Hall. Animals were housed among litter mates until isolated overnight
for challenge. Isolated animals were separated by genotype and sex. On the days of challenges,
TIGR4 aliquots were removed from -80°C and resuspended in 900 μL 1X PBS, then further
diluted to a working dilution of 2 x 106 CFU/mL. Fifty microliters of working dilution TIGR4 or
1X PBS were administered intranasally. Twenty-four hours post-infection (p.i.), mice were
humanely euthanized. To determine CFU within tissues, infected mice were necropsied and
their nasopharyngeal tissues were flushed with filter-sterilized 1X PBS, lungs homogenized in 1
mL 1X PBS, and blood drawn retroorbitally. Crude samples were appropriately diluted to
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determine CFU titres onto TSA supplemented with 5% sheep’s blood and incubated overnight at
37° C under CO2. Tracheae were surgically transversely severed and whole pulmonary tissues
were prepared as follows: transferred to 1X PBS to be homogenized for cytokine analysis;
perfused with and homogenized in Trizol (Thermo Fisher Scientific) reagent for RNA extraction
and library preparation; perfused with and transferred to 10% formalin (Thermo Fisher
Scientific) for paraffin embedding.
Histopathological analysis
Tissues were collected, fixed in 10% neutral buffered formalin, routinely processed,
embedded in paraffin, sectioned at 5 μm and stained with hematoxylin and eosin (172).
Cytokine analysis
To characterize the pneumococcal-induced cytokine profile 24 hours p.i., pulmonary
tissues were harvested as described above and blood was retroorbitally drawn. Crude tissue
homogenates were centrifuged for 10 minutes at 9,391 x g and 4°C. Supernatants were
transferred to clean tubes and stored at -80°C for analysis. Tissue homogenate pellets were
washed once with 1X PBS and centrifuged for 10 minutes at 21,130 x g and 4°C. Whole tissue
lysates were centrifuged for 4 minutes at 690 x g. Whole tissue lysates were transferred to clean
tubes and stored at -80°C for analysis. Blood samples were centrifuged for 3 minutes at 1,550 x
g. Sera were transferred to clean tubes and store at -80°C for analysis. Concentrations of
granulocyte-colony stimulating factor (G-CSF), granulocyte macrophage-colony stimulating
factor (GM-CSF), interleukin-1 alpha (IL-1α), IL-1β, IL-2, IL-4, IL-5, IL-6, IL-9, IL-10, IL12p40, IL-12p70, IL-13, IL-15, IL-17, interferon-inducible protein-10 (IP-10), keratinocytederived chemokine (KC), monocyte chemotactic protein-1 alpha (MCP-1α), macrophage
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inflammatory protein-1alpha (MIP-1α), MIP-1β, MIP-2, regulated on activation normal T cells
expressed and secreted (RANTES), tumor necrosis factor-alpha (TNF-α), and interferon-gamma
(IFN-ϒ) were determined using the MILLIPLEX MAP Mouse Cytokine/Chemokine Magnetic
Bead Panel (EMD Millipore) according to the manufacturer’s instructions.
RNA isolation and library preparation
To characterize the post-pharyngeal pulmonary transcriptome 24 hour p.i., tissues were
mechanically homogenized using an electrical grinder in 5 mL Trizol reagent. From crude
homogenates, one milliliter was transferred to a clean tube and incubated at room temperature
for 5 minutes. The remaining crude Trizol homogenate was stored at -80°C for curation and
further analysis. Two-hundred microliters chloroform (Thermo Fisher Scientific) were added,
shaken, and incubated at room temperature for 2 minutes. Samples were centrifuged 20 minutes
at 15,871 x g and 4°C. RNA was purified using the RNeasy kit (Qiagen) according to the
vendor’s instructions. RNA purity was determined by using the Qubit 2.0 fluorometer and Qubit
RNA BR and dsDNA HS assay kits (Thermo Fisher Scientific). Ten micrograms total RNA
served as starting material with the NEBNext Poly(A) mRNA Magnetic Isolation Module (New
England Biolabs), and cDNA libraries were generated using the NEBNext Ultra RNA Library
Prep Kit for Illumina (New England Biolabs). Samples of cDNA from all mice were normalized
for concentration, pooled, and sequenced on their own lane of a NOVASeq 6000 sequencer at
100 base-pair paired-end reads and yielded at least 10 million reads.
Demultiplexing, alignment, normalization, & bioinformatics analysis
RNAseq reads were trimmed with BBDuk (part of BBMap version 38.5) for both quality
(minimum quality set to 20 with: “qtrim=rl trimq=20”) and adapters trimming. Transcript
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abundances for each sample were computed with Kallisto version 0.45.0 using default
parameters (kallisto quant –bias) for pseudoalignment against the Mus musculus annotated
transcripts from the Ensembl database (GRCm39, release 103) (173, 174). Differentially
expressed genes were detected in using the DESeq2 package (175). Clustering of samples based
on gene expression patterns was performed with the vsn and pheatmap and revealed that 3
samples of infected mice clustered with mock-infected mice. Blood CFU data confirmed that the
infection status of these three mice was questionable and they were removed from the analysis
(TABLE 4). Gene Ontology enrichment was performed using the topGO package in R, using the
ks/classic statistic/algorithm combination. The entire R code used in this analysis is available at:
RNAseq analysis R code.
Results
PUMA limits pneumococcal inflammation & sepsis
To further investigate the role of Puma against pneumococcal dissemination, Puma+/+
and Puma-/- mice were intranasally infected with 2 x 105 total CFU TIGR4. At 24 h p.i., TIGR4
CFU were quantitated from nasal lavage fluid (NLF), lung homogenates, and blood (FIGURE
1A). While numbers of TIGR4 recovered from NLF were similar among all mice, Puma-/- mice
demonstrated significantly higher bacterial counts in the lungs and bloodstream at 24 h post
infection compared to Puma+/+ mice. TIGR4 disseminated rapidly from the nasopharynx 24 h
p.i. From nasopharynx to lungs, the difference in TIGR4 CFU between Puma+/+ and Puma-/increased by approximately 2.5 log (104 in Puma+/+ vs. >106 in Puma-/-). In the same timeframe,
only 47% of Puma+/+ mice exhibited TIGR4 disseminated to blood, compared to 83% of Puma-/mice. Puma-/- mice also lost significantly more weight (mean of 1.42 g) than Puma+/+ mice
(mean of 0.2 g) over the 24 h course of infection. (FIGURE 1B).
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Figure 2.1

Puma attenuates sepsis and morbidity.
5

A. Mice were intranasally challenged with 2 x 10 total CFU TIGR4. Pneumonia was allowed to
develop for 24 h, at which time mice were euthanized and tissues were sampled. A two-way
ANOVA was performed, α = 0.05. B. Mice were weighed immediately before challenge and
before sacrifice. A two-tailed, unpaired t-test was performed, α = 0.05. A and B, WT (n = 10),
KO (n = 7), and mice within each group served as biological replicates.

To characterize differences in tissue inflammation, lung sections were stained as
described in Materials and Methods. Peribronchiolar and perivascular inflammation was noted
in both Puma+/+ and Puma-/- lungs (FIGURE 2). In the Puma+/+ group, one of five mice had no
histologic changes, while four of five had patchy areas of increased cellularity of the interstitium
with three of five classified as mild. No evidence of vasculitis was detected in Puma+/+ lungs.
In the Puma-/- group, one of five mice had increased alveolar macrophages as the only histologic
change, while four of five had patchy areas of increased cellularity of the interstitium with two of
five lungs scored moderate. One Puma-/- mouse exhibited evidence of vasculitis.
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Figure 2.2

Puma protects against tissue inflammation.

A, B. WT mice exhibited mild peribronchiolar inflammation with edema and neutrophils and
macrophages. C-E. KO mice exhibited moderate peribronchiolar/perivascular inflammation,
abundant neutrophils, macrophages, vasculitis (eosinophilic material, vascular thickening). A E, for WT and KO (n = 5; 3 slides/mouse), and mice within each group served as biological
replicates; scale bar, 20 μm.

Puma dampens cytokine signaling and prevents onset of the cytokine storm
To characterize the effect of Puma on the cytokine response elicited by pneumococcus,
lung and blood cytokine levels from Puma+/+ and Puma-/- mice were quantitated 24 h p.i.
(TABLE 2). The cytokines IL-1β, -6, -12, -13, IP-10, MCP-1, MIP-1α, -1β, TNF-α, and IFN-ϒ
were significantly over-expressed in Puma-/- lungs and blood compared to those of Puma+/+.
Similarly, differences in G-CSF, GM-CSF, IL-1α, -17, KC, MIP-2, and RANTES were
significant only in lung, while IL-9, -10, and -12(p40) were only significantly different in blood.
Differences in IL-2, -4, -5, and -15 were observed in Puma+/+ and Puma-/- mouse lungs and
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blood, all concentrations being higher in Puma-/- tissues, but none were statistically significant
(FIGURE 3).
Loss of Puma induces aberrant transcriptional responses in the pulmonary transcriptome
To investigate Puma-dependent transcriptional responses during the early phase of
pneumonia, total RNA was extracted, purified, and pooled for RNA-seq analysis. Using
DEseq2, 21 differentially expressed genes, 15 of which with annotations, were detected with an
adjusted p-value < 0.05 (TABLE 3). Of note, the genes Nrxn2, Adam19, and Eln were each upregulated in Puma+/+ lungs and down-regulated in those of Puma-/- mice. Gene ontology (GO)
analysis using topGO revealed three major GO categories with p-value < 0.5: biological
processes, molecular functions, and cellular components. Fold-enrichment (FE) was calculated
for GO sub-categories within these three categories. In biological processes, 19 of 32 categories
exhibited FE values of at least 2.5. All four molecular function categories were enriched more
than 2.5-fold, and 3 of 7 categories in the cellular component group were enriched. In
accordance with detection of IL-12 cytokine, the GO group ‘positive regulation of IL-12
production’ (GO:0032735) was enriched 3.6 fold (FIGURE 4). Notably, GO groups ‘cellular
response to IFN-β’ (GO:0035458) and ‘cellular response to IFN-ϒ’ (GO:0071346) were
enriched 5.46 and 3.45, respectively.
Discussion
Apoptosis is integral in the host defense response against pneumococcal infection (8, 9,
11, 12, 32–34) . Neutrophils are the primary cell type responsible for direct clearance of
pneumococcus from the lung (176). Phagocytosis of pneumococcus induces apoptosis in
neutrophils via phagocytosis-induced cell death (PICD) (179). As neutrophils become apoptotic,
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they are rapidly cleared by macrophages to avoid the detrimental effects of secondary necrosis
and prolonged inflammation within the lung (72, 91–93, 151). Neutrophil apoptosis directly and
indirectly signals surrounding cells to aid in resolution (90, 145, 150, 180). Apoptosis of other
cell types also contributes to pneumococcal infection resolution, including macrophages (42, 94,
148, 181), epithelial cells (30, 147, 155, 182, 183), and T-cells (184). During the early innate
immune response in the lung, all of these cell types may contribute to apoptosis-induced
signaling. PUMA-induced apoptosis can occur in epithelial cells (111, 112, 120, 130, 131),
neutrophils (97, 129), and T-cells (128, 185, 186). While many cytokines have been associated
with inflammation modulation during pneumococcal infection, the pro-inflammatory IL-12/IFNϒ/IP-10 signaling axis has emerged as a potent arm of the innate immune response. Infectioninduced IL-12 secretion was first identified from dendritic cells and neutrophils and can be
induced by pneumococcus via TLR3 activation (187–189). The effects of increased IL-12
during pneumococcal pneumonia also extend to stimulating IFN-ϒ-dependent neutrophil
recruitment through enhanced expression of MIP-2 and TNF-α (49, 190). Puma+/+ mice
expressed less IL-12 in their lungs than Puma-/-. This could be due to the anti-inflammatory
effects of apoptotic neutrophils, as pro-inflammatory signaling is dampened once apoptosis is
initiated in neutrophils (90, 93). In accordance with this notion, we previously demonstrated that
Puma-/- lungs contained more neutrophils than their Puma+/+ counterparts (97). However, proinflammatory efferocytosis of neutrophils also induces an IL-12low phenotype in macrophages
(191). This likely contributes to the low levels of IL-12 in the Puma+/+ lungs, but the precise
mechanisms of temporal IL-12 production and its effect on cell death in specific cellular subsets
within the lung during early pneumococcal pneumonia need to be further investigated. The
importance of IFN-ϒ signaling is well demonstrated during the early host response to
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pneumococcal infection. At 24 h p.i., greater than 98% of IFN-ϒ detected in the lungs during
pneumococcal infection is neutrophil-derived via MyD88 signaling (58, 163). Neutrophilic
production of IFN-ϒ during early pneumococcal pneumonia is dependent upon signaling through
the non-receptor Src tyrosine kinases Hck, Fgr, and Lyn, thereby activating the small GTPase
Rac2, which leads to and is required for NADPH oxidase assembly, suggesting IFN-ϒ
production in neutrophils may be ROS-dependent (163). In the same study, IFN-ϒ production
by neutrophils also promoted neutrophil extracellular trap (NET) formation during pneumonia,
contributing to bacterial clearance. Production of IFN-ϒ in pneumococcal pneumonia models
has been linked to strain-dependent effects, and suppresses pneumococcal outgrowth during the
early phase by recruiting neutrophils (192, 193). A more recent study has corroborated and
elaborated upon these data, revealing differing expression patterns of IFN-ϒ and IP-10 signaling
in pneumococcal and staphylococcal pneumonia (194). As a ligand for the CXCR3 receptor, IP10 can recruit and activate effector CD4+ Th1, CD8+ CTL, natural killer (NK), and the hybrid
NK-T cells (195). In monocyte-derived macrophages co-infected with pneumococcus and either
Influenza virus A or respiratory syncytial virus, IP-10 production significantly increased, which
may further explain the amplified tissue damage observed in patients with such co-infections
(196, 197). In human neutrophils, the combination of IFN-ϒ and TNF-α is the most potent
inducer of IP-10 secretion (198, 199). In accordance with these observations, in vitro studies
have shown NF-κB activation induces IP-10 expression and migration of peripheral blood
leukocytes (200, 201). Pneumococcal culture supernatant can induce PLY- and CbpA-dependent
IP-10 expression in monocyte-derived dendritic cells upon interaction between IFN regulatory
factors and κB elements in peripheral blood mononuclear cells (202–204). IP-10 expression is
also strain-dependent and associated with acute lung injury during early pneumococcal
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pneumonia (51). Interestingly, secretion of IL-12 and IP-10 are increased by human peripheral
blood monocytes upon exposure to intact pneumococci, but inhibited when exposed to autolyzed
pneumococci (161). In pneumococcal pneumonia, IFN-ϒ signaling is thought to exert beneficial
effects by activating NK-T cells but detrimental effects upon activating NK cells (205). It should
also be noted that in an experimental pneumonia murine model at 24 hours p.i., T cells, NK cells,
and macrophages did not produce IFN-ϒ (163). The increase of IFN-ϒ and subsequent IP-10
production in Puma-/- mice 24 hours p.i. underscores the importance of apoptosis in resolving
inflammation. While both groups displayed increased interstitial inflammation, overall, Puma-/mice exhibited a greater degree of inflammation with multiple foci and vasculitis. The excessive
inflammation observed in the Puma-/- mice is likely a result of accumulation of neutrophils that
remain active and continue to propagate the IL-12/IFN-ϒ/IP-10 axis. Previous works of others
using murine models and data presented here strongly suggest that PUMA-dependent neutrophil
apoptosis suppresses the IL-12/IFN-ϒ/IP-10 signaling axis, thereby limiting inflammation and
consequent pneumococcal dissemination. However, it is currently unknown if the reported IL12/IFN-ϒ/IP-10 signaling in mice recapitulates the acute-phase cytokine signaling in humans.
Historically, IFN-ϒ has been ruled out as an acute-phase cytokine in humans (159). Although,
another patient study found significant differences in bronchoalveolar lavage fluid IFN-ϒ
between healthy control subjects and those with CAP and in serum between severe and nonsevere CAP patients upon admission (206). Beyond the intrinsic differences in murine and
human physiology, a likely explanation for these differences may be the temporal differences in
surveillance and detection of infection in humans, with testing only occurring within about 72
hours of the first onset of symptoms (207). Consequently, the mechanistic details of apoptotic
suppression of the IL-12/IFN-ϒ/IP-10 pro-inflammatory axis, temporospatial regulation of the
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intercellular signaling, and whether the cascade results in feedback in humans during
development of bacterial pneumonia remain unknown.
Puma-dependent responses also regulate the pulmonary transcriptome. In the lung,
ADAM19 is expressed in a variety of cell and tissue types. ADAM19 is expressed higher in
bronchiolar than alveolar epithelial cells but expressed higher in smooth muscle cells than in
bronchiolar epithelial cells (208). However, ADAM19 is only weakly expressed in vascular
endothelial cells. The detection of ADAM19 on the apical surfaces of airway epithelial cells
may suggest a role in the positive regulation in the early innate immune response to infection
since ADAM19 can induce inflammation via shedding of TNF-α (209). ADAM19 also
contributes to angiogenesis, neurogenesis, synaptogenesis, and adhesion of and invasion by
leukocytes (210–212). Several of the other ADAM family members have reportedly been
observed modulating the immune response to multiple infectious agents, including
pneumococcus (213). Down-regulation of Adam19 in Puma-/- lungs suggests an
immunomodulatory role in the early innate immune response that is short-lived due to yet
unidentified Puma-dependent responses to pneumococcal infection. Nrxn2, a member of the
neurexin gene family, encodes a transmembrane protein on pre-synaptic neurons that forms a
Ca2+-dependent complex with the protein neuroligin on post-synaptic neurons (214). In addition
to regulation of synaptic transmission in the nervous system, neurexin-neuroligin complexation
has been observed in vascular tissue. Each neurexin gene encodes a long (α) and short (β)
isoform. While the sequence mapping could not discern Nrxn2 α or β transcripts in the analysis
reported here, β isoforms have been detected in complexes with neuroligin in the vascular system
while positively modulating angiogenesis in conjunction with vascular endothelial growth factor
and increasing vascular tone (214, 215). Eln, the gene encoding elastin, was also up-regulated in
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a Puma-dependent manner. One explanation for this observation could be that the accumulation
of neutrophils in the lung and the hypoxic nature of pneumonia suppress elastin fiber deposition
and repair (216, 217). Together, these data suggest a Puma-dependent integrated systems
physiologic host response to pneumococcal pneumonia. However, the details of these
intermolecular and intercellular interactions within the lung have not been thoroughly
interrogated during infection.
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Table 2.2

-/-

Pro-inflammatory cytokine profile of Puma mice during early innate immune
response.

Lungs and blood were harvested from mice challenged with TIGR4 pneumococcus 24 p.i. More
-/than 80% of cytokines probed were significantly higher in Puma tissues. α = 0.05. For each
challenge group, Puma+/+ (n = 10), Puma-/- (n = 7), and mice within each group served as
biological replicates.
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Figure 2.3

Puma-dependent host responses during early pneumococcal pneumonia suppress
production of cytokines in the lung.

Cytokines expressed more than 3-fold in KO mouse lungs are shown here. Cytokines were
detected via magnetic bead panel using flow cytometry analysis. Values are reported as pg/mL.
Mann-Whitney tests were performed to determine significance, α = 0.05.
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Table 2.3

-/-

Differentially expressed genes in Puma lungs.

Lungs and blood were harvested from mice challenged with TIGR4 pneumococcus 24 p.i. Gene symbols with asterisks indicate
+/+
-/transcripts up-regulated in Puma and down-regulated in Puma . α = 0.05; *, genes were up-regulated in Puma+/+ and downregulated in Puma-/-; padj, p-value adjusted; lfcSE, log fold change standard error.
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Figure 2.4

Gene ontology analysis reveals Puma limits IL-12 and Type I and II IFN signaling

Genes significantly expressed (red dots) in their respective GO groups are plotted against all other genes (blue dots). Significance was
determined using the Kolmogorov-Smirnov test and p-values were adjusted for multiple-testing. The area above the black line
indicates higher expression in KO mice, while the area under the black line indicates higher expression in WT mice.
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Table 2.4

CFU counts per individual mice used in RNAseq analyses after pneumococcal challenges.

5

WT and KO mice were challenged with 2 x 10 total CFU TIGR4 or mock-infected with equivalent volumes of PBS. Lungs were
harvested as described in methods 24 h p.i. CFU were quantitated from blood. Outliers are shown in red. For each group, WT (n =
5), KO (n = 5), and mice within each group served as biological replicates.
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CHAPTER III
NEUTROPHIL CASPASE-3 ACTIVATION IS INDUCED BY PNEUMOCOCCAL H2O2 BUT
DISPENSIBLE IN PUMA-DEPENDENT APOPTOSIS
Abstract
PUMA is essential for propagation of the intrinsic apoptotic pathway leading to caspase
activation (218, 219). The role of pneumococcal H2O2 in caspase activation in Puma-dependent
apoptosis of neutrophils was investigated. Puma+/+ and Puma-/- neutrophils were exposed to
TIGR4 pneumococcus or its pyruvate oxidase knockout mutant (TIGR4:ΔspxB). Pneumococcal
H2O2 induced DNA fragmentation, a common feature of apoptosis, in a Puma-dependent
manner. Apoptosis was also detected by annexin V-FITC/Sytox blue positivity. TIGR4:ΔspxB
induced significantly less apoptosis than TIGR4 in Puma+/+ and Puma-/- neutrophils, and Puma-/neutrophils were significantly less susceptible to the apoptotic effects of pneumococcal H2O2.
However, the pan-caspase inhibitor z-VAD-FMK failed to abrogate this effect. Cleavage of
caspase-3, the predominant executioner caspase of neutrophils, was investigated by western blot.
Caspase-3 cleavage was diminished in Puma+/+ and Puma-/- neutrophils upon stimulation by
TIGR4:ΔspxB. These data suggest alternative endogenous protease families are at play during
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apoptosis induced by pneumococcal H2O2 in neutrophils and extend recent findings to
neutrophils as a potential drug target (220).
Introduction
After induction of the intrinsic apoptotic pathway, caspase activation leads to
inflammation, DNA damage, and cell death (221). These events can be stimulated by intrinsic or
extrinsic apoptosis. As the names imply, extrinsic apoptosis is instigated when external
environmental conditions, including paracrine signaling from other cells in the environment,
dictate the cell should die, and intrinsic apoptosis is typically initiated by intracellular signaling,
usually by intracellular injury. Previous studies have demonstrated a hierarchical activation of
caspases in apoptotic cells triggered to undergo apoptosis by the intrinsic apoptotic pathway.
However, these data are often dependent upon cell type and the stimulus. Caspases-8 and -9 are
potent activator caspases in T-cells, but caspase-9 is activated during intrinsic apoptosis, while
caspase-8 is activated during extrinsic apoptosis (221). Exposure of epithelial cells to
pneumococcus induces caspase-6 activation (147). Caspase-3 is required for DNA
fragmentation and later morphological changes seen in apoptotic cells, but not the early events of
nuclear morphological changes (222, 223). These observations may also be dependent upon
specific activation by various BCL2 family member proteins. Expression and activity of the
BH3-only members (Bid, Bad, Bim, Bmf, Hrk, Noxa, Puma, and Bik) are extensively regulated.
Puma is transcriptionally regulated by a number of mechanisms (224). Puma expression and
caspase-9 activation were shown to mutually regulate one another, leading to activation of
caspase-3 and induce apoptosis (225). Recently, PUMA was shown to mediate epithelial cell
apoptosis during Helicobacter pylori in a gastric infection model (130). During neutrophil
apoptosis, endogenously-generated ROS modulate caspase activation (226). PLY released from
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pneumococci during autolysis induces endogenous ROS by neutrophils (227). PLY and
pneumococcal H2O2 induce apoptosis in neutrophils, and caspase-3 is chemically induced by
H2O2 (96, 228). In inflammatory cells, pneumococcus activates the inflammatory caspase-1 via
PLY (229). During meningitis and pneumonia, PLY and H2O2 induce DNA damage and
apoptosis (26, 30, 230).

However, the major effectors of pneumococcal H2O2-induced

neutrophil apoptosis have yet to be characterized. Here, we investigated Puma-dependent effects
on cell death after assault by pneumococcal H2O2.
Materials & Methods
Bacterial culture
Bacterial cultures were prepared as in MATERIALS & METHODS in CHAPTER II.
Tissue culture & neutrophil experiments
Immortalized Hoxb8 Puma+/+ and Puma-/- neutrophil progenitors were maintained in
RPMI 1640 (Thermo Fisher Scientific) supplemented with 10 ng/mL stem cell factor (SCF,
(97)), 10% fetal bovine serum (FBS; Atlanta Biologicals), 100 U/mL penicillin (Thermo Fisher
Scientific), 100 μg/mL (Thermo Fisher Scientific) streptomycin, and 1 μM β-estrogen (SigmaAldrich). Progenitors were sub-cultured at a concentration of 5 x 105 cells/5 mL in β-estrogensupplemented medium for two days, at which time cells were reseeded to 2 x 106 cells/10 mL in
β-estrogen-supplemented medium for two days. After culturing for two days, β-estrogen was
removed from progenitors by washing thrice in 1X PBS supplemented with 1% FBS each at 690
x g for 5 minutes. Progenitors were reseeded to 3 x 106 cells/20 mL RPMI 1640 supplemented
with 10 ng/mL SCF, 10% FBS, 100 U/mL penicillin, and 100 μg/mL streptomycin and
differentiated for four days. Differentiated neutrophils were washed once in RPMI 1640
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supplemented with 10 ng/mL SCF and 10% FBS at 690 x g for 5 minutes and enriched for live
cells by isotonic Percoll (Thermo Fisher Scientific) centrifugation at 690 x g for 30 minutes at
25° C. Enriched cells were washed once in 1X PBS supplemented with 1% FBS at 690 x g for 5
minutes. Neutrophils were resuspended at 1 x 106 cells/mL and exposed to TIGR4 or
TIGR4:ΔspxB at an MOI of 1:1 for 2 hours, and washed once and resuspended in RPMI 1640
supplemented with 10% FBS, 10 μg/mL penicillin, and 0.2 mg/mL gentamicin for the remainder
of the experiment. Samples were rotated at 37°C in a humidified CO2-fed incubator for the
entire duration of the experiments.
DNA extraction
Neutrophils were exposed to pneumococcus as above. After washing with antibioticsupplemented medium, cells were incubated for another two hours. At the end of experiments,
cells were washed once in iced 1X PBS as above and lysed in 500 μL TES (0.1 M Tris-HCl, 0.15
M NaCl, 0.1 M EDTA, pH 8.0) buffer and 50 μL 1% Triton X-100 (Thermo Fisher Scientific) in
TES were added. Crude lysates were incubated at 37°C for 15 minutes. RNA was digested by
adding 50 μL of 10 μg/mL RNase A (Worthington Biochemical Corporation) and incubated at
37°C for 15 minutes with inversion every 5 minutes. Protein was digested by adding 20 μL 20
mg/mL proteinase K (Worthington Biochemical Corporation) and incubated at 37°C for 30
minutes. DNA was phenol:chloroform-extracted (Thermo Fisher Scientific) from crude lysates
and ethanol precipitated (Thermo Fisher Scientific). Concentrations of purified DNA were
quantitated by spectrophotometry with a NanoDrop 1000 (Thermo Fisher Scientific) and A260/280
ratios were used to determine purity. A total of 1 μg DNA per sample was electrophoresed
through 0.5X TBE-2% agarose (MIDSCI) with 0.002% ethidium bromide (Thermo Fisher
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Scientific) at 100 V for two hours and immediately imaged in a BioRad Gel Doc 2000 gel
imager.
Flow cytometry
Neutrophils were exposed to pneumococcus as above or etoposide (Sigma-Aldrich) at 5
μg/mL final concentration. For samples receiving the pan-caspase inhibitor, zVAD-FMK
(zVAD; EMD Millipore), inhibitor was added at a final concentration of 10 μg/mL immediately
before stimuli were applied to neutrophils. After washing with antibiotic-supplemented medium,
inhibitor was added back for the remainder of the experiment. Single stain controls were treated
with etoposide and stained with FITC-annexin V (BD Biosciences) or Sytox blue (Thermo
Fisher Scientific). At the end of experiments, cells were washed once at 690 x g for 3 minutes in
iced 1X PBS. Cells were dual stained with FITC-annexin V and Sytox blue in a total volume of
100 μL 1X annexin V-binding buffer (BD Biosciences). All controls and samples were analyzed
from 10,000 total events counted. Initial gating was set from unstained cells to distinguish cells
from debris. Single stain controls were then gated by forward (FSC) and side (SSC) scatter.
Dual stained samples were subsequently analyzed for single and dual positivity by quadrant
gating based on Puma+/+ negative control staining.
Western blotting
Neutrophils were exposed to pneumococcus as above or etoposide at 5 μg/mL final
concentration. After washing with antibiotic-supplemented medium, cells were incubated for
another two hours. At the end of experiments, cells were washed once in iced 1X PBS as above
and lysed in RIPA (Thermo Fisher Scientific) (500 μL/1 x 107 cells) supplemented with
protease/phosphatase inhibitor cocktail (Cell Signaling Technology). Lysates were frozen at
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least once at -20°C. Before use in blots, lysates were homogenized by sonication and refrozen.
Protein concentrations of lysates were quantitated by BCA assay (Thermo Fisher Scientific).
Twenty micrograms total protein were resolved through 12.5% acrylamide gels by SDS-PAGE
in TGS buffer (Thermo Fisher Scientific). Protein was wet transferred from gel to 0.45 μm
PVDF (EMD Millipore) in iced TG buffer (Thermo Fisher Scientific). After transferring,
membranes were washed once in TTBS (900 mL ultra-pure water, 100 mL 10X TBS (60.57 g
Tris-base, 80.65 g NaCl, 6.8 mL 3M KCl, 19 mL 10N HCl), and 0.5 mL Tween-20)), Ponceau S
(Sigma-Aldrich) stained to confirm protein transfer, then destained in 0.1 M NaOH. Membranes
were washed at least three times in ultra-pure water before being washed once more in 1X
TTBS. Membranes were blocked in 5% dried, non-fat milk (Walmart) in 1X TTBS for one hour
and probed with a polyclonal rabbit anti-mouse antibody against caspase-3 (pro- and cleaved;
Cell Signaling Technology) in 5% milk, 1X TTBS, and 0.02% NaN3 (Sigma-Aldrich) overnight.
Membranes were washed in 1X TTBS four times for five minutes each after removing the
primary, anti-caspase-3 antibody and probed with secondary goat anti-rabbit HRP-conjugated
antibody (Bio-Rad Laboratories) for two hours. Membranes were washed four times for five
minutes each after removing the secondary antibody. The HRP-substrate Pico Plus (Thermo
Fisher Scientific) was used in combination with autoradiographic film (Thermo Fisher Scientific)
to detect the presence of cleaved caspase-3. Detection of β-actin (Cell Signaling Technology)
served as the loading control.
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Results
Puma-dependent neutrophil death is induced by pneumococcal H2O2
Using activation of caspase-3 as a marker of neutrophil apoptosis, the role of
pneumococcal H2O2 was investigated. Western blotting revealed that pneumococcal H2O2 is a
potent activator of caspase-3 (FIGURE 5A). However, caspase-3 activation within these
exposure conditions did not appear to be Puma-dependent. To investigate cell death even
downstream of caspase-3 activation, DNA fragmentation induced by pneumococcal H2O2 in
Puma+/+ and Puma-/- neutrophils was investigated. Like caspase-3 activation, DNA
fragmentation in neutrophils was strongly abrogated after exposure to TIGR:ΔspxB. Unlike
activation of caspase-3, DNA fragmentation did occur in a Puma-dependent manner (FIGURE
5B).
Pneumococcal H2O2-induced neutrophil apoptosis is Puma-dependent but not caspasedependent.
To investigate the role of Puma in apoptosis induced by pneumococcal H2O2, dual
staining flow cytometry analysis was used to detect progression of apoptosis in Puma+/+ and
Puma-/- neutrophils. After exposure to TIGR4, Puma-/- neutrophils were more resistant to killing
than Puma+/+ neutrophils, exhibiting attenuated shifts from early to late-stage apoptosis (approx.
7% to 20% vs. 8% to 40%) (FIGURE 6A). Exposure to TIGR:ΔspxB returned apoptotic
measurements to negative control values in both Puma+/+ and Puma-/- neutrophils. Changes in
annexin V positivity in Puma+/+ neutrophils were statistically significant (neg ctrl vs. TIGR4 and
TIGR4 vs. TIGR:ΔspxB). Decreases observed between Puma-/- neutrophils exposed to TIGR4
and TIGR:ΔspxB were also statistically significant (FIGURE 6B). The dependence of caspase
activation was investigated using the pan-caspase inhibitor zVAD-FMK (zVAD). Regardless of
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genotype, zVAD failed to attenuate previously demonstrated annexin V positivity levels in
neutrophils exposed to TIGR4, suggesting caspase-independent mechanisms in Puma-dependent
apoptosis (FIGURE 6B).
Discussion
PUMA has historically been investigated within the context of cancer biology, as it is a
p53-inducible transcript and facilitates propagation of the long-studied apoptotic cascade.
However, these data suggest a role for PUMA in the alternative apoptotic pathway named
caspase-independent cell death (CICD). CICD signaling can be executed by a number of
proteases independently of caspase activation, including calpains, cathepsins, apoptosis-inducing
factor (AIF), granzymes (A and B), and endonucleases (231, 232). Calpains can also contribute
to cell death (apoptosis and necrosis) in coordination with and independent of caspases.
Calpains contribute to caspase-dependent regulated necrosis by their contributions to
nucleosomal release along with damage-associated molecular patterns (233). However, the lowmolecular weight, internucleosomal fragments (a general marker of apoptosis) seen in neutrophil
nuclear DNA after exposure to pneumococcal H2O2 suggests apoptosis is being triggered, rather
than necrosis. Calpains and cathepsins are activated downstream of RIPK1/RIPK3 activation, a
major initial trigger of necrosis (234). MLKL, a major kinase involved in positively regulating
necrosis, could not be detected by western blots in whole-cell neutrophil lysates (data not
shown), further casting doubt on necrosis as the major death pathway being triggered. The
effects of H2O2 can also induce necrosis (235). However, with the exception of capsule and
PLY, the effects of H2O2 in the hierarchy of additional pneumococcal stimuli assaulting
neutrophils are not thoroughly characterized. A role for PUMA should not be entirely ruled out,
though, as PUMA-mediated necrosis was recently demonstrated in drug-induced liver injury
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(236). Notably, ER stress has been implicated in programmed cell death dependent and
independent of the mitochondrial damage cascade (134). Since most cells that undergo apoptosis
under physiologically relevant conditions do so through the mitochondrial-ER stress axis, the
induction of Chop demonstrates a likely role for ER stress activation by pneumococcal H2O2 in
neutrophils (237). Pneumococcus may be a potent inducer of ER stress-mediated induction of
Puma via crosstalk between cell death pathways (237, 238). PERK, one of the major signal
transducers of ER stress, is activated by pneumococcal H2O2 (29). Interestingly, ER stress can
dysregulate Ca2+ homeostasis, which, in turn activates calpains. Activated calpains trigger
lysosomes to release cathepsins. These caspase-independent events form what has been called
the calpain-cathepsin cascade (239). Others have reported pneumococcal H2O2 –induced ER
stress (29). However, the role for this virulence factor activating the calpain-cathepsin cascade
in neutrophils remains to be characterized.
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Figure 3.1

Puma-dependent neutrophil death is induced by pneumococcal H2O2.

A. Caspase-3 is activated by pneumococcal H2O2 but not Puma-dependent. Neutrophils were
exposed to pneumococci. Twenty micrograms total protein were resolved through 12% SDSPAGE, transferred, and probed for cleaved caspase-3 and β-actin. B. Puma promotes DNA
fragmentation through the oxidative effects of pneumococcal H2O2. Neutrophils were rotated
unstimulated (neg ctrl) or exposed to pneumococci and DNA was extracted, quantitated, and
electrophoresed through 2% agarose in 0.5X TBE. Lanes with asterisks above were used to
electrophorese 1 kb plus ladder (Thermo Fisher Scientific). A and B. Images are representative
of two independent technically repeated experiments.
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Figure 3.2

Pneumococcal H2O2-induced neutrophil apoptosis is Puma-dependent but not caspase-dependent.

A. Neutrophils exposed to TIGR4 or TIGR4:ΔspxB were dual-stained and analyzed by flow cytometry. Deletion of spxB abrogated
apoptotic effects of pneumococcal killing of neutrophils.
B. Experiments were repeated with a pan-caspase inhibitor (zVAD) to investigate caspase-dependent apoptosis. zVAD did not inhibit
pneumococcal-induced apoptosis. Scatter plots are representative of two independent technically repeated experiments (n =2). Bars
graphed represent means ± SD of two independent experiments. A two-way ANOVA was performed, α = 0.05. Etop, etoposide.
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CHAPTER IV
PUMA IS INDUCED BY P53-INDEPENDENT MECHANISMS BUT INHIBITION FAILS
TO RESCUE NEUTROPHILS FROM CELL DEATH
Abstract
Puma can be induced by p53-independent mechanisms. After exposing Puma+/+ and
p53-/- neutrophils to TIGR4 or TIGR4:ΔspxB, qPCR analysis was used to investigate p53independent ER stress-related induction of Puma. Greater detection of both Chop and Puma
were observed in p53-/- neutrophils after exposure to TIGR4 than TIGR4:ΔspxB. However,
exposure to EF3030, a low H2O2-producing clinical isolate, induced both Chop and Puma to a
greater extent in p53-/- neutrophils than did TIGR4. Using p53-null HL-60 neutrophils
transduced with an NF-κB luciferase reporter, pneumococcal H2O2-induced NF-κB activation
was assayed. The NF-κB and ER stress inhibitor sodium 4-phenylbutyric acid (4-PBA) neither
inhibited luminescence stimulated by strains TIGR4 and EF3030, nor did 4-PBA attenuate cell
death induced by TIGR4 or EF3030. While pneumococcus induces ER stress, NF-κB activation,
and Puma expression, neither ER stress nor NF-κB activation appear to be intensively induced
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by pneumococcal H2O2. These findings suggest that early pneumonia treatment may be beyond
the intervention of pharmaceutics targeting these pathways (240, 241).
Introduction
Through the effects of H2O2, pneumococcus can induce a robust ER stress response via
the unfolded-protein response, activation and nuclear translocation of NF-κB, and neutrophil
chemotaxis to the lung (29, 84). The oxidative assault can also trigger DNA damage-induced
apoptosis and amplify TLR-dependent inflammatory cytokine signaling in pulmonary epithelial
cells (30, 84). Pneumococcal H2O2 can also accelerate apoptosis in neutrophils (96). Several
bacterial pathogens can modulate the neutrophil transcriptome and influence cell fate by
promoting expression of pro-apoptotic genes and suppressing anti-apoptotic genes (242, 243).
Expression of multiple genes by detection of transcripts or protein modification have been
developed as ER stress markers (85). We attempted to investigate the role of pneumococcal
H2O2 in the expression of Chop and Puma, activation of NF-κB, and ER stress-induced
apoptosis.
Materials & Methods
Bacterial culture
Bacterial cultures were prepared as in MATERIALS & METHODS in CHAPTER II.
Tissue culture & neutrophil experiments
Hoxb8 neutrophil progenitors were subcultured, differentiated, and prepared as in
MATERIALS & METHODS in CHAPTER II. Thapsigargin was used a positive control to
induce specific ER stress. Sodium 4-phenylbutyric acid (4-PBA), an ER stress inhibitor, was
used to determine ER stress-dependent cell death.
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HL-60 promyelocytes were subcultured in IMDM (Thermo Fisher Scientific)
supplemented with 20% FBS, 100 U/mL penicillin, and 100 μg/mL streptomycin. To
differentiate, HL-60 cells were washed once in culture medium and seeded to 3 x 106 cells/20
mL culture medium supplemented with 1.5% dimethyl sulfoxide (DMSO; Corning, Inc) and
cultured for six days.
Lentiviral transduction
HEK293T cells were transfected in a T-75 tissue culture flask with 20 μg of pLenti-NFκB-Luc-GFP, 10 μg of psPAX2, and 2 μg of pMD2.G with 57 μL of TransIT-2020 reagent. The
DNA/transfection reagent mixture was prepared in 1.9 mL of OptiMEM and then added
dropwise to cells. Cells were incubated for 72 hours and the lentivirus-containing media was
harvested. Cells were refed with 10 mL new media. The viral suspension was centrifuged at
560 x g for 10 minutes, and the supernatant was filter-sterilized with a 0.45 μm PVDF syringe
filter then stored at 4° C. Viral suspensions were harvested again at 96 hours and 120 hours and
combined with the 72 hours and concentrated with an Amicon Ultra-15 (10,000 NMWL) in a
final volume of 1 mL. Polybrene was added to a final concentration of 8 μg/mL to the
concentrated viral suspension and gently mixed. The viral suspension was added to target cells
(1 x 106 cells/well in 6 well plate) by centrifugation at 1000 x g for 1 hour. Transduced cells
were incubated for 24 hours, at which time the medium was changed.
Luciferase assays
After six days of differentiation, mature HL-60 granulocytes were washed once in IMDM
supplemented with 20% FBS and diluted to 1 x 106 cells/mL in RPMI 1640 supplemented with
10% FBS. Cells were exposed to TIGR4 or EF3030 at an MOI of 1:1 or phorbol 12-myristate
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13-acetate (PMA, 60 μM; Sigma-Aldrich) or thapsigargin (TG, 2 μM; Sigma-Aldrich) for 1 hour
and cells were washed once and resuspended in 1 mL RPMI 1640 supplemented with 10% FBS,
10 μg/mL penicillin G, and 0.2 mg/mL gentamicin. Samples were rotated at 37°C in a
humidified CO2-fed incubator for the entire duration of the experiments. Fifty microliters of cell
suspension were transferred to individual wells of a black plate with clear bottom and lid
(Corning, Inc.). Fifty microliters of BrightGlo (Promega) substrate-lysis buffer mix were added
to cells and incubated at room temperature for 5 minutes. Luminescence was read using Gen5
software on a BioTek Synergy plate reader at a sensitivity level of 250.
qRT-PCR
Neutrophils were incubated for 2 hours after washing in antibiotic-supplemented medium
and washed in iced 1X PBS. RNA was extracted using the Qiagen RNeasy Mini Kit per the
provided protocol with an amended 1 h on-column DNA digestion using DNase I (Qiagen),
eluted in 50 μL RNase free water, and stored at -80°C. RNA and contaminating DNA were
quantitated using RNA BR and dsDNA HS assay kits (Invitrogen) in conjunction with Qubit
assay tubes (Thermo Fisher Scientific) and a Qubit 2.0 fluorometer (Thermo Fisher Scientific).
cDNA was synthesized using a Maxima First Strand cDNA synthesis kit (ThermoFisher). qRTPCR was conducted with 5 ng cDNA template and PrimeTime assays (IDT) for Puma (Bcl-2 –
binding component-3, Bbc3; Mm.PT.58.7446951), Chop (Ddit3; Mm.PT.58.30882054), and βActin (Actb; Mm.PT.39a.22214843.g) in an Applied Biosystems StepOnePlus Real-Time PCR
System thermal cycler. qRT-PCR were conducted within the following parameters: 50° C for 2
minutes, 95° C for 10 minutes, and (95° C for 15 seconds, 60° C for 1 minute) x 40 cycles.
Efficiency ratings were reported by the vendor between 90 and 110 %. Neither standard curves
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nor melt curves were performed. Expression of Chop and Puma were normalized to endogenous
levels of β-Actin expression, and fold-change was determined using ΔΔCt analysis relative to the
negative control (unstimulated neutrophils). Statistical analysis was performed using GraphPad
Prism.
Flow cytometry
Neutrophils were incubated for 6 hours after washing in antibiotic-supplemented medium
and washed in iced 1X PBS. For 4-PBA-inhibited samples, 4-PBA (100 μM; Sigma-Aldrich)
was added immediately before adding stimuli. After washing in antibiotic-supplemented
medium, 4-PBA was added back for the duration of experiments. Samples were stained and
analyzed as described in CHAPTER III MATERIALS & METHODS.
Results
Neutrophil ER stress induction by pneumococcus is strain dependent
To investigate the potency of pneumococcal H2O2 in the activation of ER stress,
differentiated neutrophils were exposed to TIGR4, TIGR4:ΔspxB, or EF3030 and subsequently
probed for expression of the ER stress-induced transcription factor Chop. Induction of Chop was
observed at 4 hours post-exposure to TIGR4 (FIGURE 7). Deletion of spxB in TIGR4
attenuated Chop expression. However, exposure to the lower H2O2-producer EF3030 induced
Chop to a greater extent than TIGR4. Activation of ER stress was also enhanced in p53-/neutrophils, with Chop induction nearly doubled after exposure to EF3030, though CHOP
protein could not be detected by western blot (data not shown). Contrarily, Chop was downregulated when exposed to TIGR4:ΔspxB.
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Figure 4.1

Pneumococcus induces differential gene expression depending upon p53 status.

Neutrophils were exposed to indicated pneumococci.RNA was extracted and quantitated by
fluorometry.Five nanograms total cDNA was probed for (A) chop and (B) puma. Results are
representative of two independent technically repeated experiments (n = 2). Bars graphed
represent means ± SD. Deletion of ΔspxB in TIGR4 attenuated chop and puma expression. A
two-way ANOVA was performed, α = 0.05. No statistical significance was detected in chop
-/expression between wt and p53 neutrophils; TG, thapsigargin; Etop, etoposide.
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Pneumococcal induction of Puma occurs by p53-independent mechanisms
Puma induction in neutrophils was investigated by qRT-PCR 4 hours post-exposure to
pneumococcus. No significant induction of Puma was observed in wild-type neutrophils after
exposure to TIGR4, TIGR4:ΔspxB, or EF3030, nor could the PUMA protein be detected by
western blot (data not shown). However, in p53-/- neutrophils, TIGR4 and EF3030 induced
Puma approximately 2- and 3-fold, respectively. Similar to Chop, TIGR4:ΔspxB exposure
down-regulated Puma in p53-/- neutrophils, although not significantly.
Pneumococcal H2O2 contributes to activation of NF-κB
The contribution of H2O2 in pneumococcal activation of NF-κB in neutrophils was
investigated using a lentiviral transduced luciferase reporter system in HL-60 cells. After
exposure to TIGR4, luciferase activity increased nearly 1.5-fold (FIGURE 8). Exposure to
EF3030 did not induce luciferase activity.
Inhibition of NF-κB activation and ER stress does not attenuate pneumococcal-induced
apoptosis
The roles of NF-κB activation and ER stress in apoptosis were investigated using the
inhibitor 4-PBA. Puma-/- neutrophils were more resistant to killing by TIGR4 and EF3030 than
Puma+/+ neutrophils (FIGURE 9). However, these effects were not inhibited by the NF-κB and
ER stress inhibitor 4-PBA. To specifically induce ER stress, neutrophils were exposed to a
range of TG. Regardless of TG concentration, 4-PBA failed to abrogate ER stress-induced cell
death (data not shown). Likewise, 4-PBA was tested against H2O2-induced death in neutrophils,
again failing to attenuate these effects (data not shown).
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Figure 4.2

Pneumococcus activates NF-κB in a strain-dependent manner.

Transduced HL-60 cells were differentiated and stimulated with pneumococci. Fifty microliters
per sample were sampled, transferred to a well of a clear-bottom, black-sided multi-well plate
and lysed in luciferase substrate lysis buffer. Luciferase activity was detected on a luminometer
and represented as relative luminescence units (RLU). Results shown are from a single
experiment (n = 1).
Discussion
Pneumococcal H2O2 is a potent inducer of ER stress during development of pneumonia.
Using Chop induction as a molecular marker, ER stress was detected in neutrophils. Chop was
up-regulated after exposure to TIGR4 and EF3030, but expression was attenuated after exposure
to TIGR4:ΔspxB as expected. However, since EF3030 produces approximately 6-fold less H2O2
(data not shown) than TIGR4, it was noteworthy that EF3030 induced Chop more effectively
than TIGR4. However, blockage of ER stress failed to inhibit apoptosis in neutrophils,
suggesting that one or more signals in addition to ER stress are required to induce apoptosis.
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Figure 4.3

Pneumococcal-induced neutrophil apoptosis is not ER stress-mediated.

Neutrophils were exposed to indicated pneumococci, dual-stained, and analyzed by flow
cytometry. The ER stress inhibitor 4-PBA failed to rescue neutrophils from killing by
pneumococci, regardless of strain. Apoptosis is represented as % FITC-annexin V positivity.
Results are from a single experiment (n = 1).
In p53-/- neutrophils, this pattern of Chop induction between TIGR4 and EF3030 was
recapitulated and exacerbated. In lieu of H2O2 activating ER stress, a possible explanation for
this observation is instigation of ER stress by peptidoglycan, lipotheicoic acid, and lipoprotein
activation of NOD 1 and 2 receptors (244–246). CHOP, also referred to as DNA damageinducible transcript 3 (DDIT3) and growth arrest and DNA damage-inducible protein
(GADD153), is induced during DNA damage response signaling. Both TIGR4 and EF3030
produced PLY (247). PLY can also activate ER stress signaling in cardiomyocytes but doesn’t
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induce Chop or activate caspase-3 (248). The patterns of Chop induction reported here may be
cell type-specific, but the contributing effects of H2O2 on PLY release from pneumococci within
the context of this model should be interrogated, as PLY can contribute to DNA damage and
apoptosis (25, 230). Additionally, in p53 mutant cells, various stimuli can induce Chop
expression, and CHOP can recapitulate cell death via ER stress signaling (249–252). PUMA
also mediates ER stress-mediated apoptosis (253–255). However, whether Puma induction in
neutrophils by pneumococcus is ER stress-dependent requires further investigation. The p53-ER
stress signaling axis is a growing area of interest and further investigations in neutrophils
continue to be of importance.
H2O2 modulates the activity of several mammalian transcription factors (256). NF-κB
activation, translocation, and DNA-binding can be modulated by H2O2 (257). Using the NF-κBluciferase assay reporter system, NF-κB activation by pneumococcus was determined. NF-κB
was activated by TIGR4 but not EF3030 after 1 hour of exposure. These observations contradict
those from previous studies focusing on NF-κB activation by H2O2 in neutrophils (258, 259).
However, purely chemical induction models of NF-κB activation do not take into account the
additive complexities of Gram-positive bacterial components, including lipoteichoic acid, cell
surface proteins, and peptidoglycan. Pneumococcus can induce NF-κB activation in murine
pneumonia and expression of many cytokines from innate immune cells necessary for
appropriate inflammatory signaling, including neutrophils recruitment (78, 83, 202, 260, 261).
To the best of our knowledge, we report here for the first time pneumococcal activation of NFκB in a strain-dependent manner in neutrophils.
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CHAPTER V
PUMA-DEPENDENT RESPONSES WITHIN THE HOST: WHAT PUMA ADDS TO THE
FIELD AND HOW THESE OBSERVATIONS CAN GUIDE
THERAPEUTIC APPROACHES
Summary
Building upon our initial Puma studies, we have made several advancements in
characterizing the early, cell-mediated, host innate immune response to pneumococcal
pneumonia. Using Puma-/- mice, we have demonstrated the pro-resolving effects of Puma in
suppressing cytokine over-activation and attenuating the consequent inflammation. Previous
works of others have characterized the highly potent, pro-inflammatory IL-12/IFN-ϒ/IP-10
signaling axis during pneumococcal pneumonia. Here, we demonstrate that prohibition of
expression of each cytokine in this axis is dependent upon the protective effects of Puma.
However, whether the vast increase in IFN-ϒ is a mechanistic cause or effect of the pathology
observed in Puma-/- lungs requires further investigation. Since administration of exogenous,
recombinant IFN-ϒ is currently employed in treatment of infections in patients with chronic
granulomatous disease (e.g., Actimmune and Immukin), this may suggest, like many other
cytokines, generation of IFN-ϒ is finely balanced, and excessive levels may contribute to poorer
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outcomes during infection. On the other hand, our GO analyses revealed Type I IFN signaling
was induced by pneumococcus, which has also been previously reported (262–264). While we
did not probe for IFN-β, one of the two major Type I IFN isoforms, genes associated with this
GO group skewed heavily toward the Puma-/- lung samples. Given the pro-apoptotic effects
associated with Puma, as well as other BH3-only proteins, and the importance of neutrophil
shutdown in resolution of infectious inflammation, it is likely that many of these signaling events
are, in part, modulated by Puma-dependent cell death responses. One potential intervention
strategy in augmenting the resolving effects of apoptosis in experimental models of bacterial
infection is to investigate the efficacy of BH3-only-inducing chemicals (e.g., etoposide,
thapsigargin, and curcumin) during the development of bacterial pneumonia.
Our in vitro neutrophil experiments ruled out the possibility of caspase-dependent cell
death mechanisms, although caspase-3 was activated by pneumococcal H2O2. However, in
accordance with morphological and intracellular changes of neutrophils, it is likely that an
alternative family of proteases are involved in Puma-dependent apoptosis. Two such families are
the calpains and cathepsins. Calpains are likely activated downstream of caspases, can be
activated in response to oxidative stress, and can be activated independent of p53 (231). These
observations are in agreement with our data, as pneumococcal H2O2 activated caspase-3 in
Puma-/- neutrophils, although Puma-dependent cell death was not caspase-dependent.
Alternatively, cathepsin-dependent apoptosis can be induced via the TNFR activation. Cathepsin
activity can also induce Bax activation and eventual loss of mitochondrial membrane integrity
(231). Additionally, PLY can induce calpain activation in macrophages (265). Inhibition of
each of the caspase, calpain, and cathepsin families has been demonstrated in one or more animal
or tissue culture models. However, most of these inhibitors do not perform well translationally
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when used clinically (220). The pan-caspase inhibitor zVAD was used in a model of
experimental pneumococcal meningitis to limit neuronal apoptosis and consequent neutrophil
recruitment to cerebrospinal fluid (266). As is thought to be the case in the lung, brain damage
in pneumococcal meningitis is augmented by host innate immune factors. The efficacy and
safety of zVAD in experimental pneumococcal pneumonia has yet to be validated. However, to
determine the efficacy of zVAD in inhibiting the detrimental effects of the innate response in the
lungs in our Puma model, apoptosis of lung cells should also be determined. Also, how these
parameters would be determined clinically is unknown considering that patients diagnosed with
bacterial pneumonia generally seek medical intervention well beyond the first 24 hours of
infection. Based upon clinical observations recapitulated in animal models, therapeutic
intervention of acute bacterial pneumonia should be oriented toward inhibiting the activity of
pro-inflammatory cytokines, such as IFN-ϒ and IFN-inducible proteins (e.g., IP-10).
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